Ocular Melanoma — Trials

Ocular Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 62
Recruiting: 32
Ph III recruiting: 6
Growth YoY: —
Industry share: 35%
Top sponsor: IDEAYA Biosciences
Termination share: 31.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (36)

clinicaltrialsPublishedShowing 251–254 of 254 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00540930	Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy	unknown	Phase 4	400	Shields, Shields and AssociatesOTHER	1	Oct 8, 2007	clinicaltrials
NCT00168870	Study of Metastatic Ocular Melanoma	unknown	Phase 2	48	Charite University, Berlin, GermanyOTHER	1	Aug 31, 2007	clinicaltrials
NCT00406900